var data={"title":"Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">William L Weston, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">William Howe, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Robert P Dellavalle, MD, PhD, MSPH</a></dd><dd><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Moise L Levy, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Joseph Fowler, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Rosamaria Corona, MD, DSc</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Oct 11, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Atopic dermatitis is a chronic pruritic inflammatory skin disease that occurs most frequently in children, but also affects adults. Atopic dermatitis is often associated with elevated serum level of immunoglobulin E and a personal or family history of atopy, which describes a group of disorders that includes eczema, asthma, and allergic rhinitis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/1,2\" class=\"abstract_t\">1,2</a>]. Although sensitization to environmental or food allergens is clearly associated with the atopic dermatitis phenotype, it does not seem to be a causative factor but may be a contributory factor in a subgroup of patients with severe disease [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/3\" class=\"abstract_t\">3</a>]. (See <a href=\"topic.htm?path=role-of-allergy-in-atopic-dermatitis-eczema\" class=\"medical medical_review\">&quot;Role of allergy in atopic dermatitis (eczema)&quot;</a>.)</p><p>The terms &quot;dermatitis&quot; and &quot;eczema&quot; are frequently used interchangeably. When the term &quot;eczema&quot; is used alone, it often refers to atopic dermatitis (atopic eczema). The term &quot;eczematous&quot; also connotes some crusting, serous oozing, or blister formation as opposed to mere erythema and scale.</p><p>The epidemiology, pathogenesis, clinical manifestations, and diagnosis of atopic dermatitis are reviewed here. The treatment of atopic dermatitis, the role of allergy in atopic dermatitis, and other types of eczematous dermatitis are discussed separately.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=treatment-of-atopic-dermatitis-eczema\" class=\"medical medical_review\">&quot;Treatment of atopic dermatitis (eczema)&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=management-of-severe-atopic-dermatitis-eczema-in-children\" class=\"medical medical_review\">&quot;Management of severe atopic dermatitis (eczema) in children&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=role-of-allergy-in-atopic-dermatitis-eczema\" class=\"medical medical_review\">&quot;Role of allergy in atopic dermatitis (eczema)&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-allergic-contact-dermatitis\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of allergic contact dermatitis&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=cradle-cap-and-seborrheic-dermatitis-in-infants\" class=\"medical medical_review\">&quot;Cradle cap and seborrheic dermatitis in infants&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=seborrheic-dermatitis-in-adolescents-and-adults\" class=\"medical medical_review\">&quot;Seborrheic dermatitis in adolescents and adults&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Atopic dermatitis affects approximately 5 to 20 percent of children worldwide [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/4\" class=\"abstract_t\">4</a>]; in the United States, it is approximately 11 percent [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/5\" class=\"abstract_t\">5</a>]. Data on the prevalence of atopic dermatitis in adults are limited and in most cases based upon self-administered questionnaire information. In a Danish population-based study including approximately 16,500 adults aged 30 to 89 years, the one-year prevalence of atopic eczema was 14 percent [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/6\" class=\"abstract_t\">6</a>]. In a West Sweden study of approximately 30,000 individuals aged 16 to 75 years, the current eczema prevalence was 11 percent [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/7\" class=\"abstract_t\">7</a>]. In a Danish cohort study including approximately 1300 individuals aged 28 to 30 years who had been followed-up for 15 years, 10 percent reported atopic dermatitis, but 6 percent were found to have atopic dermatitis at clinical examination [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/8\" class=\"abstract_t\">8</a>].</p><p>The incidence of atopic dermatitis appears to be increasing. It may occur in any race or geographic location, although there appears to be a higher incidence in urban areas and developed countries, especially Western societies. A systematic review of epidemiologic studies performed between 1990 and 2010 found an increasing trend in incidence and prevalence of atopic eczema in Africa, eastern Asia, western Europe, and parts of northern Europe [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/9\" class=\"abstract_t\">9</a>].</p><p>In the vast majority of cases, atopic dermatitis has an onset before age five years, and prevalence data in children show a slight female to male preponderance (1.3 to 1) [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/10\" class=\"abstract_t\">10</a>]. Persistent atopic dermatitis may be present in approximately 50 percent of patients diagnosed with atopic dermatitis during childhood [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/8,11\" class=\"abstract_t\">8,11</a>].</p><p class=\"headingAnchor\" id=\"H55133484\"><span class=\"h1\">RISK FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A family history of atopy (eczema, asthma, or allergic rhinitis) and the loss-of-function mutations in the filaggrin (<em>FLG</em>) gene, involved in the skin barrier function, are major risk factors for atopic dermatitis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/12\" class=\"abstract_t\">12</a>]. (See <a href=\"#H5\" class=\"local\">'FLG mutations'</a> below.)</p><p>Approximately 70 percent of patients have a positive family history of atopic diseases. Children with one atopic parent have a two- to threefold increased risk of developing atopic dermatitis, and the risk increases to three- to fivefold if both parents are atopic [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/2\" class=\"abstract_t\">2</a>].</p><p>Although 30 to 80 percent of patients with atopic dermatitis are sensitized to certain foods, the timing of solid food introduction or food avoidance strategies in pregnant or nursing women does not appear to influence the risk of atopic dermatitis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/13\" class=\"abstract_t\">13</a>]. (See <a href=\"topic.htm?path=role-of-allergy-in-atopic-dermatitis-eczema#H4\" class=\"medical medical_review\">&quot;Role of allergy in atopic dermatitis (eczema)&quot;, section on 'Food allergies'</a>.)</p><p>There is evidence from a 2011 systematic review to support an inverse relationship between atopic dermatitis and exposure to endotoxin, early day care, farm animal, and dog pets in early life (the &quot;hygiene hypothesis&quot;) [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/14\" class=\"abstract_t\">14</a>].</p><p>Epidemiologic evidence from ecologic studies linked high hardness (high levels of <a href=\"topic.htm?path=calcium-carbonate-drug-information\" class=\"drug drug_general\">calcium carbonate</a>) of domestic water with increased prevalence of atopic dermatitis in children [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/15-18\" class=\"abstract_t\">15-18</a>]. A United Kingdom population-based cross-sectional study including 1303 three-month-old infants suggests that hard water may increase the risk of developing atopic dermatitis early in life [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/19\" class=\"abstract_t\">19</a>]. In this study, a high water level of calcium carbonate, but not of chlorine, in the household water was associated with a nearly doubled risk of visible atopic dermatitis compared with low calcium carbonate water, after adjusting for potential confounders (presence of filaggrin mutation, sex, ethnicity, and maternal age). However, residual confounding from unmeasured factors, such as changes in skin care practices associated with presence of eczema or dry skin, cannot be excluded. Further studies are needed to evaluate whether the installation of water softening devices is helpful for the prevention of atopic dermatitis in high-risk infants.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A multiplicity of factors, including skin barrier abnormalities, defects in innate immunity response, Th2-skewed adaptive immune response, and altered skin resident microbial flora are involved in the pathogenesis of atopic dermatitis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/20,21\" class=\"abstract_t\">20,21</a>]. Whether skin inflammation is initiated by skin barrier dysfunction (&quot;outside-in&quot; hypothesis) or by immune dysregulation (&quot;inside-out&quot; hypothesis)&nbsp;is still in debate.</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Epidermal barrier</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The epidermis is the first line of defense between the body and the environment. The skin barrier keeps environmental irritants, allergens, and microbes from entering the body and prevents excessive water loss. The barrier function of the skin is primarily located in the stratum corneum, which consists of vertical stacks of anucleate corneocytes packed with keratin filaments embedded in a matrix of filaggrin breakdown products [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/22\" class=\"abstract_t\">22</a>]. The corneocyte layers are embedded in an extracellular matrix replete with multiple lamellar bilayers enriched in ceramides, cholesterol, and free fatty acids derived from secreted lamellar body precursor lipids [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/23\" class=\"abstract_t\">23</a>].</p><p>The permeability of the epidermis is determined by complex interactions between terminal differentiated keratinocytes on the surface of the skin and groups of structural proteins, such as filaggrin, regulatory enzymes, and lipids. Filaggrin deficiency is a major determinant of defective barrier function [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/12\" class=\"abstract_t\">12</a>]. Other factors that can result in skin barrier breakdown include imbalance between stratum corneum protease (eg, kallikrein, stratum corneum chymotryptic enzyme) and antiprotease activity (eg, LEKTI), tight junction abnormalities, microbial colonization, and release of proinflammatory cytokines [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/24\" class=\"abstract_t\">24</a>]. The tight junctions are located in the stratum granulosum below the stratum corneum and are thought to seal the intercellular space to prevent the free diffusion of macromolecules [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/25\" class=\"abstract_t\">25</a>].</p><p>The epidermis of patients with atopic dermatitis is characterized by a genetically impaired skin barrier function with increased transepidermal water loss [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/26\" class=\"abstract_t\">26</a>]. These abnormalities may be present at birth and predict the development of atopic dermatitis in the first year of life [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/27\" class=\"abstract_t\">27</a>]. Higher levels of transepidermal water loss in patients with atopic dermatitis have been associated with greater disease severity [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/28,29\" class=\"abstract_t\">28,29</a>].</p><p class=\"headingAnchor\" id=\"H58962847\"><span class=\"h3\">Filaggrin</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Filaggrin is a protein produced by differentiating keratinocytes encoded by the <em>FLG</em> gene on the 1q21 epidermal differentiation complex, a cluster of more than 70 genes encoding proteins involved in skin barrier formation and differentiation of stratified epithelia [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/30,31\" class=\"abstract_t\">30,31</a>]. The cells of the granular layer contain dense cytoplasmic granules primarily composed of profilaggrin, with other protein components required for the formation of the corneocytes that are responsible for the barrier function of the skin.</p><p>Following its synthesis, profilaggrin undergoes extensive phosphorylation, is stored in keratohyalin granules, and subsequently dephosphorylated, resulting in the formation of filaggrin monomers that have keratin-filament-aggregating properties.&nbsp;The hygroscopic free amino acids and their derivatives, such as pyrrolidone carboxylic acid and trans-urocanic acid, resulting from the breakdown of filaggrin, are major components of the natural moisturizer factor (NMF) [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/31\" class=\"abstract_t\">31</a>]. NMF maintains skin hydration and water retention within the stratum corneum in conditions of low environmental humidity.</p><p class=\"headingAnchor\" id=\"H55102489\"><span class=\"h3\">Other proteins in the stratum corneum</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition to filaggrin, other skin barrier-related proteins may be defective in atopic dermatitis skin. In one study, proteomic profiling of patients with atopic dermatitis revealed that filaggrin-2, corneodesmosin, desmoglein-1, desmocollin-1, transglutaminase-3, and enzymes involved in the production of natural moisturizing factor (eg, arginase-1, caspase-14, and gamma-glutamyl cyclotransferase) were expressed at lower levels in lesional sites than in normal skin [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>].</p><p class=\"headingAnchor\" id=\"H55102333\"><span class=\"h3\">Tight junction-related proteins</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Abnormalities of the tight junction function located in the granular layer of the epidermis may contribute to the decreased skin barrier function observed in atopic dermatitis. Tight junctions are composed of a number of transmembrane proteins, such as proteins of the claudin family, junctional adhesion molecule (JAM)-A, occludin, and tricellulin. A reduced expression of the tight junction protein claudin-1 has been demonstrated in nonlesional skin of individuals with atopic dermatitis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/33\" class=\"abstract_t\">33</a>].</p><p class=\"headingAnchor\" id=\"H14448090\"><span class=\"h2\">Genetics</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A genetic basis for atopic dermatitis is suggested by twin studies that have found concordance rates of 80 percent for monozygotic twins compared with 20 percent for dizygotic twins [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/34-36\" class=\"abstract_t\">34-36</a>]. Linkage studies and meta-analyses have implicated loci associated with skin barrier abnormalities, in particular those located in the epidermal differentiation complex on chromosome 1q21, which include the filaggrin gene (<em>FLG</em>) [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/37,38\" class=\"abstract_t\">37,38</a>]. Subsequent genome-wide studies (GWAS) and meta-analyses performed in European and Asian populations have confirmed this association and identified additional susceptibility loci for atopic dermatitis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/39-42\" class=\"abstract_t\">39-42</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">FLG mutations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Loss-of-function mutations in the filaggrin gene <em>FLG</em>, including the two initially reported (R501X and 2282del4) cause ichthyosis vulgaris, the most common inherited disorder of keratinization, and are associated with a more severe phenotype of X-linked recessive ichthyosis and pachyonychia congenita [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/12,43,44\" class=\"abstract_t\">12,43,44</a>] (see <a href=\"topic.htm?path=overview-and-classification-of-the-inherited-ichthyoses\" class=\"medical medical_review\">&quot;Overview and classification of the inherited ichthyoses&quot;</a>). The same <em>FLG</em> mutations are major risk factors for atopic dermatitis and other skin and allergic diseases including irritant contact dermatitis, asthma, and food allergy [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/12,37,45\" class=\"abstract_t\">12,37,45</a>].</p><p>Two meta-analyses have confirmed the association of <em>FLG</em> mutations with atopic dermatitis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/37,45\" class=\"abstract_t\">37,45</a>]. In both studies, the risk of atopic dermatitis was more than fourfold higher in individuals carrying either one or both R501X and 2282del4 mutations, compared with noncarriers. A subsequent case-control study found that <em>FLG</em> mutations were associated with atopic dermatitis occurring at an early age (&le;8 years), but not with atopic dermatitis developing in late childhood or adulthood [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/46\" class=\"abstract_t\">46</a>]. In addition, in patients with a history of atopic dermatitis, homozygous <em>FLG</em> mutations appear to be associated with increased prevalence and persistence of hand and foot dermatitis during adulthood [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/47\" class=\"abstract_t\">47</a>]. The <em>FLG</em> genotype may also influence the response to treatment. In a cohort study of 842 children enrolled in the Pediatric Eczema Elective Registry and followed-up for an average of 7.6 years, patients with homozygous loss-of-function <em>FLG</em> mutations were less likely to report any period of skin clearance and more likely to report frequent steroid use than patients with wild-type <em>FLG</em> or heterozygous <em>FLG</em> mutations [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/48\" class=\"abstract_t\">48</a>]. </p><p class=\"headingAnchor\" id=\"H1317229342\"><span class=\"h3\">SPINK5</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The <em>SPINK5</em> gene encodes the protease inhibitor lymphoepithelial Kazal-type 5 serine protease inhibitor LEKTI that is involved in profilaggrin into filaggrin processing. LEKTI1 is deficient in Netherton syndrome, a rare autosomal recessive disorder characterized by severe atopic dermatitis and a specific hair shaft abnormality [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/49\" class=\"abstract_t\">49</a>]. LEKTI inhibits a well-characterized protease stratum corneum chymotryptic enzyme (SCCE) that is involved in cleaving the intercellular attachments between corneocytes in normal desquamation process. LEKTI deficiency results in upregulated SCCE function, increased cleavage of intercellular attachments, reduced corneocyte cohesion, and compromised barrier function [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/50\" class=\"abstract_t\">50</a>]. Several genetic association studies suggest a contribution of LEKTI deficiency to the pathogenesis of atopic dermatitis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/51-54\" class=\"abstract_t\">51-54</a>].</p><p class=\"headingAnchor\" id=\"H14448287\"><span class=\"h3\">Other genes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition to <em>FLG</em> and <em>SPINK5</em>, many other genes have been proposed as potential contributors to atopic dermatitis, including genes involved in the formation of the skin barrier or in immune regulation [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/55,56\" class=\"abstract_t\">55,56</a>].</p><p>A meta-analysis of genome-wide association study (GWAS) including approximately 11,000 atopic dermatitis cases and 40,000 controls from 30 population-based cohorts of European descent confirmed the association of atopic dermatitis with genes identified in previous GWAS (<em>FLG</em> on 1q21 and <em>TNFRSF6B</em> on 20q13) and identified three new susceptibility loci for atopic dermatitis: 5q31 (<em>KIF3A</em>), 11q13 (<em>OVOL1</em>), 19p13 (<em><span class=\"nowrap\">ADAMTS10/ACTL9</em>)</span> [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/39-41\" class=\"abstract_t\">39-41</a>].</p><p><em>KIF3A</em> encodes a component of the kinesin complex involved in assembly of cilia; <em>OVOL1</em> belongs to a highly conserved family of genes involved in the regulation of the development and differentiation of epithelial tissues and germ cells; and <em>ADAMTS</em> are a group of complex secreted zinc-dependent metalloproteinases, which bind to and cleave extracellular matrix components and are involved in connective tissue remodeling and extracellular matrix turnover and inhibiting T-cell chemotaxis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/57\" class=\"abstract_t\">57</a>].</p><p>Mutations in the gene <em>TMEM79</em>, encoding the protein mattrin, involved in the regulation of lamellar body assembly, have been found in patients with atopic dermatitis who lack <em>FLG</em> mutations [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/58\" class=\"abstract_t\">58</a>]. This finding suggests that not only inherited deficiencies in structural proteins, but also mutations that impair the delivery of lamellar body contents may be a predisposing factor for atopic dermatitis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/22\" class=\"abstract_t\">22</a>].</p><p class=\"headingAnchor\" id=\"H79161793\"><span class=\"h2\">Immune dysregulation</span></p><p class=\"headingAnchor\" id=\"H143637185\"><span class=\"h3\">Innate immune response</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The innate immune system is the first-line rapid-response mechanism to prevent microbial invasions. It consists of four major components: the physical barrier (stratum corneum and intercellular junctions); antimicrobial peptides (AMPs), cytokines, and chemokines; antigen-presenting cells, keratinocytes, mast cells, and PMNs; and the skin-resident normal microbial flora [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/20\" class=\"abstract_t\">20</a>]. The exposure to microorganisms through a defective or injured physical barrier initiates a rapid, innate immune response that prevents further microbial invasion and replication.</p><p>Keratinocytes and antigen-presenting cells in the skin express a number of innate immune receptors called pattern recognition receptors, which include toll-like receptors (TLRs). Stimulation of TLRs by tissue damage or microorganisms leads to the release of a wide range of inflammatory mediators, including AMPs, cytokines, and chemokines, and enhances the strength of tight junctions to further limit the penetration of allergens and microorganisms [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/59\" class=\"abstract_t\">59</a>]. An additional function of TLRs is to induce dendritic cell maturation, which determines the character and magnitude of the adaptive immune response [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/60\" class=\"abstract_t\">60</a>]. (See <a href=\"topic.htm?path=an-overview-of-the-innate-immune-system\" class=\"medical medical_review\">&quot;An overview of the innate immune system&quot;</a>.)</p><p>Patients with atopic dermatitis have been found to have reduced TLR2 and TLR9 function [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/20,60\" class=\"abstract_t\">20,60</a>]. A defect in this innate immune-mediated epidermal barrier repair process may lead to alteration in the skin microbiome and more severe inflammation, as seen in patients with atopic dermatitis who are colonized with <em>Staphylococcus aureus</em> [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/61\" class=\"abstract_t\">61</a>]. While in normal skin AMPs production is upregulated by two cytokines, IL-17 and IL-22, secreted by Th17 T and Th22 cells, this effect is abrogated in atopic skin by the presence of Th2 cytokines [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/62\" class=\"abstract_t\">62</a>].</p><p class=\"headingAnchor\" id=\"H323533778\"><span class=\"h3\">Adaptive immune response</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The enhanced allergen penetration through an impaired skin barrier resulting in a Th2-type milieu has been proposed as the critical link between the primary barrier defect in patients with atopic dermatitis and Th2 polarization [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/21\" class=\"abstract_t\">21</a>]. This hypothesis is supported by the observation that in filaggrin-null mouse models with phenotypic and histologic features of ichthyosis vulgaris, the topical application of allergens or protein antigens resulted in IgE-mediated allergic sensitization and characteristic skin changes of atopic dermatitis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/63\" class=\"abstract_t\">63</a>].</p><p>The acute initiation of atopic dermatitis lesions is characterized by increased expression of Th2, Th22, and Th17 cytokines [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/64\" class=\"abstract_t\">64</a>]. Th2 and Th22 cytokines (IL-4, IL-13, IL-31, and IL-22) appear to modulate the epidermal barrier function by suppressing the expression of terminal keratinocyte differentiation genes (eg, <em>FLG</em>, loricrin, involucrin), inhibiting the production of AMPs, and promoting epidermal hyperplasia [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/64\" class=\"abstract_t\">64</a>]. (See <a href=\"topic.htm?path=the-adaptive-cellular-immune-response\" class=\"medical medical_review\">&quot;The adaptive cellular immune response&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H143636767\"><span class=\"h3\">Thymic stromal lymphopoietin</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Thymic stromal lymphopoietin (TSLP) is an IL-7-like cytokine highly expressed in the epithelial cells at barrier surfaces (eg, skin, gut, lung).&nbsp;TSLP&nbsp;promotes the development of na&iuml;ve T helper cells into inflammatory Th2 cells and may be a critical factor linking defective barrier function to Th2 responses to epicutaneous allergen exposure [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/65-68\" class=\"abstract_t\">65-68</a>].&nbsp;<em>TSLP</em> polymorphisms have been proposed as markers of disease severity. A multicenter case-control study demonstrated an association between variants of the <em>TSLP</em> gene and risk of atopic dermatitis and eczema herpeticum (EH) [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/69\" class=\"abstract_t\">69</a>]. Moreover, genetic variants of <em>TSLP</em> have been associated with a decreased likelihood of having persistent atopic dermatitis, even in individuals with <em>FLG</em>&nbsp;loss-of-function mutations [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/70\" class=\"abstract_t\">70</a>].</p><p class=\"headingAnchor\" id=\"H98844203\"><span class=\"h1\">PATHOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Histologically, atopic dermatitis is characterized by epidermal changes, including spongiosis (epidermal edema), with varying degrees of acanthosis and hyperkeratosis, accompanied by a lymphohistiocytic infiltrate in the dermis. In the acute phase, the histological picture is dominated by spongiosis, an intercellular epidermal edema that leads to stretching and eventual rupture of the intercellular attachments, with the formation of vesicles.</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span></p><p class=\"headingAnchor\" id=\"H1974708121\"><span class=\"h2\">Common features</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Dry skin and severe pruritus are the cardinal signs of atopic dermatitis. However, the clinical presentation is highly variable, depending upon the patient's age and disease activity.</p><p>Acute eczema is characterized by intensely pruritic erythematous papules and vesicles with exudation and crusting, whereas subacute or chronic lesions present as dry, scaly, or excoriated erythematous papules. Skin thickening from chronic scratching (lichenification) and fissuring may develop over time. In many patients, lesions in different stages may be present at the same time.</p><p>Most patients with atopic dermatitis have a cutaneous hyperreactivity to various environmental stimuli, including exposure to food and inhalant allergens, irritants, changes in physical environment (including pollution, humidity, etc), microbial infection, and stress [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/24\" class=\"abstract_t\">24</a>].</p><p>Atopic dermatitis occurs in the first year of life in 60 percent of cases and by the age of five years in nearly 85 percent of cases. The clinical presentation at various ages is outlined below [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/71\" class=\"abstract_t\">71</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In infants and young children (zero to two years), atopic dermatitis typically presents with pruritic, red, scaly, and crusted lesions on the extensor surfaces and cheeks or scalp (<a href=\"image.htm?imageKey=ALLRG%2F77457%7EALLRG%2F56461%7EDERM%2F77386\" class=\"graphic graphic_picture graphicRef77457 graphicRef56461 graphicRef77386 \">picture 1A-C</a>). There is usually sparing of the diaper area (<a href=\"image.htm?imageKey=DERM%2F68746\" class=\"graphic graphic_picture graphicRef68746 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/71\" class=\"abstract_t\">71</a>]. Acute lesions can include vesicles, and there can be serous exudates and crusting in severe cases.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In older children and adolescents (2 to 16 years), atopic dermatitis is characterized by less exudation and often demonstrates lichenified plaques in a flexural distribution, especially of the antecubital and popliteal fossae, volar aspect of the wrists, ankles, and neck (<a href=\"image.htm?imageKey=DERM%2F68215%7EPC%2F65407%7EPC%2F52163%7EDERM%2F55424\" class=\"graphic graphic_picture graphicRef68215 graphicRef65407 graphicRef52163 graphicRef55424 \">picture 3A-D</a>) [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/71\" class=\"abstract_t\">71</a>]. The sides of the neck may show a reticulate pigmentation, the so-called &quot;atopic dirty neck&quot; (<a href=\"image.htm?imageKey=DERM%2F102395\" class=\"graphic graphic_picture graphicRef102395 \">picture 4</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In adults, atopic dermatitis is considerably more localized and lichenified. The areas involved are in most cases the skin flexures (<a href=\"image.htm?imageKey=DERM%2F64525%7EDERM%2F55375\" class=\"graphic graphic_picture graphicRef64525 graphicRef55375 \">picture 5A-B</a>). Less frequently, the dermatitis may involve the face, neck (<a href=\"image.htm?imageKey=DERM%2F102395\" class=\"graphic graphic_picture graphicRef102395 \">picture 4</a>), or hands [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/71,72\" class=\"abstract_t\">71,72</a>].</p><p/><p>In all age groups, any area of the body can be involved in severe cases, although it is uncommon to see lesions in the axillary, gluteal, or groin area; lesions in these locations should prompt consideration of other diagnoses such as psoriasis, allergic contact dermatitis, or seborrheic dermatitis. (See <a href=\"#H13\" class=\"local\">'Differential diagnosis'</a> below.)</p><p>Up to 80 percent of patients with atopic dermatitis have increased serum immunoglobulin E (IgE) levels, often with increased eosinophilia. The IgE level tends to vary with disease severity, although some patients with severe disease have normal IgE values.</p><p class=\"headingAnchor\" id=\"H43807123\"><span class=\"h2\">Associated features</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with atopic dermatitis may present a variety of cutaneous findings, so-called atopic stigmata, which include centrofacial pallor, white dermographism, keratosis pilaris (<a href=\"image.htm?imageKey=DERM%2F60786%7EDERM%2F68488\" class=\"graphic graphic_picture graphicRef60786 graphicRef68488 \">picture 6A-B</a>), palmar hyperlinearity, pityriasis alba (<a href=\"image.htm?imageKey=DERM%2F60866\" class=\"graphic graphic_picture graphicRef60866 \">picture 7</a>), periorbital darkening and Dennie-Morgan infraorbital folds (<a href=\"image.htm?imageKey=DERM%2F62145\" class=\"graphic graphic_picture graphicRef62145 \">picture 8</a>), thinning or absence of the lateral portion of the eyebrows (Hertoghe's sign), infra-auricular and retroauricular fissuring, and nipple eczema [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/73\" class=\"abstract_t\">73</a>]. Although considered minor diagnostic criteria, these findings are frequently seen and may be supportive of the diagnosis of atopic dermatitis in some patients.</p><p class=\"headingAnchor\" id=\"H3942787364\"><span class=\"h2\">Clinical variants</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Regional and morphologic variants of atopic dermatitis have been described in both children and adults [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/73,74\" class=\"abstract_t\">73,74</a>]. They may be the only manifestation of atopic dermatitis or occur in association with the classic age-related manifestations. Regional variants include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Atopic hand eczema &ndash; Atopic&nbsp;hand eczema typically involves the volar wrists and dorsum of the hands. It is most common in adults with a history of atopic dermatitis who no longer have dermatitis in typical areas (eg, flexural), especially in those who are exposed to &quot;wet-work&quot; environments [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/75\" class=\"abstract_t\">75</a>]. Concurrent foot eczema has been reported in approximately one-third of patients with atopic hand eczema [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/76\" class=\"abstract_t\">76</a>]. (See <a href=\"topic.htm?path=chronic-hand-eczema\" class=\"medical medical_review\">&quot;Chronic hand eczema&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Eyelid eczema &ndash; Eyelid dermatitis is a common feature of atopic dermatitis and, in some patients, may be the only manifestation [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/77\" class=\"abstract_t\">77</a>]. It is often associated with lichenification and presence of Dennie-Morgan lines.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Atopic cheilitis &ndash; Lip eczema or &quot;cheilitis sicca&quot; is a common manifestation of atopic dermatitis, characterized by dryness, peeling, and fissuring of the lips (<a href=\"image.htm?imageKey=DERM%2F91322\" class=\"graphic graphic_picture graphicRef91322 \">picture 9</a>). The clinical appearance may be indistinguishable from irritant or allergic cheilitis. (See <a href=\"topic.htm?path=cheilitis\" class=\"medical medical_review\">&quot;Cheilitis&quot;</a>.)</p><p/><p>Morphologic variants include nummular, prurigo nodularis-type, and follicular type atopic dermatitis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/74,78\" class=\"abstract_t\">74,78</a>]. (See <a href=\"topic.htm?path=nummular-eczema\" class=\"medical medical_review\">&quot;Nummular eczema&quot;</a> and <a href=\"topic.htm?path=prurigo-nodularis\" class=\"medical medical_review\">&quot;Prurigo nodularis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4291280\"><span class=\"h2\">Clinical course and complications</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Atopic dermatitis follows a chronic relapsing course over months to years. Patients with mild disease may experience intermittent flares with spontaneous remission, but patients with moderate to severe dermatitis rarely clear without treatment. </p><p>The majority of patients are clear of eczema by late childhood, but the disease may persist into adulthood in a variable proportion of cases [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/6,8,79-81\" class=\"abstract_t\">6,8,79-81</a>]. A pooled analysis of 45 studies including over 110,000 subjects found that 20 percent of cases of childhood atopic dermatitis had persistent disease eight years after the diagnosis and less than 5 percent 20 years after the diagnosis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/82\" class=\"abstract_t\">82</a>]. The age of onset was the main factor associated with persistence of atopic dermatitis. The hazard ratio was 2.65 (95% CI 2.54-2.75) for onset at age two to five years, 4.22 (95% CI 3.86-4.61) for onset at age 6 to 11 years, and 2.04 (95% CI 1.66-2.49) for age of onset at 12 to 17 years, compared with age of onset &lt;2 years. Other risk factors for persistence were disease severity and duration and female sex. Hypersensitivity to one or more allergens did not seem to influence the persistence of atopic dermatitis.</p><p>Patients with atopic dermatitis are predisposed to the development of bacterial and viral skin infections. Because <em>Staphylococcus aureus</em> colonizes nearly 100 percent of patients, impetiginization of lesions of atopic dermatitis is frequent and is associated with disease exacerbation. However, infection from community-acquired methicillin-resistant <em>Staphylococcus</em> <em>aureus</em> is uncommon among children with atopic dermatitis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/83-85\" class=\"abstract_t\">83-85</a>].</p><p>Eczema herpeticum, also called Kaposi's varicelliform eruption,&nbsp;is the rapid dissemination of a herpes simplex viral infection on the affected skin of patients with atopic dermatitis (<a href=\"image.htm?imageKey=PC%2F64142%7EPC%2F74838%7EPC%2F51337\" class=\"graphic graphic_picture graphicRef64142 graphicRef74838 graphicRef51337 \">picture 10A-C</a>). Eczema herpeticum is a rare complication, occurring in less than 3 percent of patients with atopic dermatitis. Severe eczema, high levels of serum IgE, and history of food allergy or asthma appear to be predisposing factors [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/86\" class=\"abstract_t\">86</a>].</p><p class=\"headingAnchor\" id=\"H80247225\"><span class=\"h1\">COMORBIDITIES</span></p><p class=\"headingAnchor\" id=\"H86702391\"><span class=\"h2\">Allergic rhinitis, asthma, and food allergy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with atopic dermatitis and genetic predisposition to produce IgE following exposure to allergens may develop a typical sequence of atopic dermatitis, allergic rhinitis, and asthma at certain ages (the &quot;atopic march&quot;) [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/1,87,88\" class=\"abstract_t\">1,87,88</a>]. A cohort study including nearly 4000 children with at least three years of follow-up found that the cumulative incidence of seasonal allergies and asthma during the follow-up was higher among children with atopic dermatitis onset before age 2 than among those with onset at ages 3 to 7 or 8 to 17 (39, 32, and 30 percent, respectively) [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/89\" class=\"abstract_t\">89</a>]. However, since the age at onset was self-reported, a misclassification bias cannot be excluded.</p><p>Patients with atopic dermatitis also have an increased risk of food-induced <span class=\"nowrap\">urticaria/anaphylaxis</span> [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/90,91\" class=\"abstract_t\">90,91</a>]. Studies suggest that environmental exposure to food allergens through an impaired skin barrier is a plausible route for food sensitization and allergy [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/92,93\" class=\"abstract_t\">92,93</a>]. In one study of 512 children younger than 15 months with a history of atopic dermatitis, exposure to peanut antigen in household dust was associated with a twofold increased risk of peanut sensitization and peanut allergy [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/94\" class=\"abstract_t\">94</a>]. However, although in infants and young children the rate of food sensitization is high, ranging from approximately 30 to 60 percent, depending upon the population and diagnostic test, the actual rate of confirmed food allergy is much lower [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/90,95-99\" class=\"abstract_t\">90,95-99</a>]. Thus, serum immunoglobulin E (IgE) should not be used for the diagnosis of food allergy in the absence of clinical reactions to the ingestion of a certain food. (See <a href=\"topic.htm?path=food-allergy-in-children-prevalence-natural-history-and-monitoring-for-resolution\" class=\"medical medical_review\">&quot;Food allergy in children: Prevalence, natural history, and monitoring for resolution&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H55134481\"><span class=\"h2\">Ichthyosis vulgaris</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Approximately 10 to 30 percent of patients with atopic dermatitis have ichthyosis vulgaris [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/100,101\" class=\"abstract_t\">100,101</a>]. Hyperlinear palms (<a href=\"image.htm?imageKey=DERM%2F90481\" class=\"graphic graphic_picture graphicRef90481 \">picture 11</a>) and keratosis pilaris are usually present in patients with atopic dermatitis and ichthyosis vulgaris. (See <a href=\"topic.htm?path=overview-and-classification-of-the-inherited-ichthyoses#H16647233\" class=\"medical medical_review\">&quot;Overview and classification of the inherited ichthyoses&quot;, section on 'Ichthyosis vulgaris'</a> and <a href=\"topic.htm?path=keratosis-pilaris\" class=\"medical medical_review\">&quot;Keratosis pilaris&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H4291555\"><span class=\"h2\">Eye diseases</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ocular comorbidities occurring in patients with atopic dermatitis include atopic&nbsp;keratoconjunctivitis (AKC) and vernal keratoconjunctivitis (VKC). AKC is a chronic allergic ocular disease that occurs most often in adults with a history of atopic dermatitis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/102\" class=\"abstract_t\">102</a>]. VKC most commonly occurs in children living in warm, dry subtropical climates [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/103\" class=\"abstract_t\">103</a>]. Ocular itching, burning, tearing, and mucus discharge are common symptoms. Complications include keratoconus, infectious keratitis, and blepharitis. (See <a href=\"topic.htm?path=atopic-keratoconjunctivitis\" class=\"medical medical_review\">&quot;Atopic keratoconjunctivitis&quot;</a> and <a href=\"topic.htm?path=vernal-keratoconjunctivitis\" class=\"medical medical_review\">&quot;Vernal keratoconjunctivitis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H86702411\"><span class=\"h2\">Obesity and metabolic syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The association between atopic dermatitis and obesity in children and adults is controversial [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/104-108\" class=\"abstract_t\">104-108</a>]. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a multicenter case-control study, 132 children aged 4 to 17 years with moderate to severe atopic dermatitis were compared with 143 children with other skin problems [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/104\" class=\"abstract_t\">104</a>]. Children with atopic dermatitis were more likely than controls to have a body mass index (BMI) in the 97<sup>th</sup> percentile or higher and a waist circumference in the 85<sup>th</sup> percentile or higher (odds ratio [OR] 2.64, 95% CI 1.15-6.06, and OR 3.92, 95% CI 1.50-10.26, respectively). In addition, atopic dermatitis was associated with a higher percentile of systolic and diastolic blood pressure after controlling for age, sex, and family history of hypertension. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A cross-sectional analysis of data from the Canadian Partnership for Tomorrow Project, including nearly 260,000 Canadian residents aged 30 to 74 years, of whom approximately 21,000 had a history of atopic dermatitis, found that atopic dermatitis was associated with a mild reduction in the risk of hypertension (OR 0.87, 95% CI 0.83-0.90), type 2 diabetes (OR 0.78, 95% CI 0.71-0.84), myocardial infarction (OR 0.87, 95% CI 0.75-1.00), and stroke (OR 0.79, 95% CI 0.66-0.95), after adjusting for age, sex, ethnic background, BMI, smoking 100 cigarettes, weekly alcohol intake, average daily sleep, and weekly physical activity [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/109\" class=\"abstract_t\">109</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A 2015 systematic review and meta-analysis of 30 observational studies found that being overweight and obese were associated with increased prevalence of atopic dermatitis in Asian and North American populations (OR 1.23, 95% CI 1.11-1.41, and OR 1.47, 95% CI 1.21-1.79, respectively) [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/110\" class=\"abstract_t\">110</a>]. </p><p/><p>However, the mechanisms underlying this association are largely unknown.</p><p class=\"headingAnchor\" id=\"H1208373967\"><span class=\"h2\">Anemia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>An analysis of caregiver-reported and self-reported data on over 200,000 children and adolescents from the United States National Health Interview Survey 1997 to 2013 found that children with a history of atopic disorders, including eczema, asthma, hay fever, or food allergy, have an increased risk of anemia (for eczema, OR 1.83, 95% CI 1.58-2.13) [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/111\" class=\"abstract_t\">111</a>]. The risk was much higher in children with all four disorders (adjusted OR 7.87, 95% CI 5.17-12). Using laboratory data from the National Health and Nutrition Examination Survey 2014 to 2015 on over 30,000 children, the authors found that children with a current history of atopic eczema had a twofold increased risk of anemia, particularly microcytic anemia (OR 2.03, 95% CI 1.20-3.46).</p><p>Whether anemia in atopic children is related to chronic inflammation or malnutrition secondary to dietary restrictions in patients suspected to have food allergies is unknown. Further ad hoc designed studies are needed to confirm this association and clarify the underlying mechanisms.</p><p class=\"headingAnchor\" id=\"H28253721\"><span class=\"h2\">Psychiatric disorders</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is a growing body of evidence that a number of psychiatric disorders and symptoms, including impaired psychosocial functioning, attention deficit hyperactivity disorder, depression, and anxiety disorders are more common among adults and children with atopic dermatitis than in the general population [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/112-114\" class=\"abstract_t\">112-114</a>]. The association of atopic dermatitis with psychosocial distress and other psychiatric disorders may be influenced by the perceived disease severity and other factors that affect negatively the quality of life, such as the loss of sleep, disabling pruritus, and social embarrassment [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/113\" class=\"abstract_t\">113</a>].</p><p class=\"headingAnchor\" id=\"H371998464\"><span class=\"h3\">Attention deficit hyperactivity disorder</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The results of a 2010 systematic review of 20 studies including over 170,000 individuals and several subsequent observational studies suggest an association between atopic dermatitis and attention deficit hyperactivity disorder (ADHD) [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/112,115-118\" class=\"abstract_t\">112,115-118</a>]. The mechanisms underlying ADHD and atopic dermatitis are unknown. Sleep disturbance secondary to nocturnal pruritus, elevated levels of psychological stress, and the effects of proinflammatory cytokines on brain development are the leading hypotheses to explain this association [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/118-120\" class=\"abstract_t\">118-120</a>]. (See <a href=\"topic.htm?path=attention-deficit-hyperactivity-disorder-in-children-and-adolescents-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis&quot;</a> and <a href=\"topic.htm?path=attention-deficit-hyperactivity-disorder-in-adults-epidemiology-pathogenesis-clinical-features-course-assessment-and-diagnosis\" class=\"medical medical_review\">&quot;Attention deficit hyperactivity disorder in adults: Epidemiology, pathogenesis, clinical features, course, assessment, and diagnosis&quot;</a> and <a href=\"topic.htm?path=attention-deficit-hyperactivity-disorder-in-children-and-adolescents-epidemiology-and-pathogenesis\" class=\"medical medical_review\">&quot;Attention deficit hyperactivity disorder in children and adolescents: Epidemiology and pathogenesis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H28253734\"><span class=\"h3\">Depression and anxiety disorder</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>An analysis of data on over 90,000 children from the 2007 National Survey of Children's Health in the United States found that among children with atopic dermatitis the prevalence of depression and anxiety disorders was significantly higher than among their peers without atopic dermatitis (6.5 versus 3.4 percent and 7.3 versus 4.1 percent, respectively) and showed an increasing trend with increasing parent-reported severity of dermatitis [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/112\" class=\"abstract_t\">112</a>].</p><p>A large longitudinal cohort study using data from the Taiwan National Health Insurance Research Database from 1998 to 2008 assessed the risk of developing major depression or anxiety disorders later in life among more than 8000 adolescents and adults with atopic dermatitis and age- and sex-matched controls [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/121\" class=\"abstract_t\">121</a>].</p><p>This study found that patients with atopic dermatitis had an increased risk of developing major depression (hazard ratio [HR] 6.56, 95% CI 3.64-11.84), any depressive disorder (HR 5.44, 95% CI 3.99-7.44), and anxiety disorders (HR 3.57, 95% CI 2.55-4.98).</p><p class=\"headingAnchor\" id=\"H406735829\"><span class=\"h1\">RISK OF LYMPHOMA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The association between atopic dermatitis and lymphoma is controversial [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/122,123\" class=\"abstract_t\">122,123</a>]. A 2015 systematic review and meta-analysis of 4 cohort studies and 18 case-control studies found a modest increase in the risk of lymphoma in patients with atopic dermatitis compared with the general population [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/124\" class=\"abstract_t\">124</a>]. The risk increase was significant in the meta-analysis of the cohort studies (relative risk [RR] 1.43, 95% CI 1.12-1.81) but not in the case-control studies (odds ratio [OR] 1.18, 95% CI 0.94-1.47). However, the large heterogeneity of case-control studies in study design and diagnostic criteria does not allow any definite conclusion.</p><p>Three of the studies included in this meta-analysis reported a significant association between severity of atopic dermatitis and cutaneous T-cell lymphoma (CTCL) [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/125-127\" class=\"abstract_t\">125-127</a>]. However, this finding must be interpreted with caution because a misclassification bias cannot be excluded. Due to overlapping clinical features, CTCL cases may have been initially misdiagnosed and treated as severe atopic dermatitis. &#160;</p><p>Finally, this meta-analysis did not find a significant association between the use of topical calcineurin inhibitors and risk of lymphoma in patients with atopic dermatitis, although one included cohort study reported a significant fivefold increased risk of lymphoma associated with the use of topical <a href=\"topic.htm?path=tacrolimus-drug-information\" class=\"drug drug_general\">tacrolimus</a> (RR 5.44, 95% CI 2.51-11.79) [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/128\" class=\"abstract_t\">128</a>]. The use of high-potency topical corticosteroids was also associated with increased risk of lymphoma (OR 1.73, 95% CI 1.52-1.97) [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/124\" class=\"abstract_t\">124</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of atopic dermatitis is clinical, based upon history, morphology and distribution of skin lesions, and associated clinical signs [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/2\" class=\"abstract_t\">2</a>]. The United Kingdom working group on atopic dermatitis published criteria for diagnosing atopic dermatitis that include one mandatory and five major criteria [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/129,130\" class=\"abstract_t\">129,130</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Evidence of pruritic skin, including the report by a parent of a child rubbing or scratching.</p><p/><p>In addition to itchy skin, three or more of the following are needed to make the diagnosis:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>History of skin creases being involved. These include: antecubital fossae, popliteal fossae, neck, areas around eyes, fronts of ankles.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>History of asthma or hay fever (or history of atopic disease in a first-degree relative for children &lt;4 years of age).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The presence of generally dry skin within the past year.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Symptoms beginning in a child before the age of two years. This criterion is not used to make the diagnosis in a child who is under four years old.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Visible dermatitis involving flexural surfaces. For children under four years of age, this criterion is met by dermatitis affecting the cheeks or forehead and outer aspects of the extremities.</p><p/><p>The UK working group's analysis excluded allergy criteria as originally proposed by Hanifin and Rajka. The UK working group data have been validated by investigators from the Netherlands [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/131\" class=\"abstract_t\">131</a>].</p><p>Skin biopsy and laboratory testing, including IgE levels, are not used routinely in the evaluation of patients with suspected atopic dermatitis and are not recommended. However, in selected patients, histologic examination of a skin biopsy or other laboratory tests (eg, serum immunoglobulin E, potassium hydroxide preparation, patch testing, genetic testing) may be helpful to rule out other skin conditions [<a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/2\" class=\"abstract_t\">2</a>]. (See <a href=\"#H13\" class=\"local\">'Differential diagnosis'</a> below.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of atopic dermatitis includes:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Allergic or irritant contact dermatitis</strong> &ndash; Allergic or irritant contact dermatitis may be difficult to differentiate from atopic dermatitis (<a href=\"image.htm?imageKey=DERM%2F51066\" class=\"graphic graphic_picture graphicRef51066 \">picture 12</a>). The localization of dermatitis to a specific skin area, history of exposure to irritants or potential sensitizers, and a relevant patch test positivity suggest the diagnosis of contact dermatitis. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-allergic-contact-dermatitis\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of allergic contact dermatitis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Seborrheic dermatitis</strong> &ndash; Seborrheic dermatitis is the most common differential diagnosis in infants (<a href=\"image.htm?imageKey=DERM%2F73813%7EDERM%2F56410%7EDERM%2F59104\" class=\"graphic graphic_picture graphicRef73813 graphicRef56410 graphicRef59104 \">picture 13A-C</a>). The two conditions may also coexist. The presence of salmon-red erythematous skin patches with greasy scale, involvement of the scalp, and little or no pruritus support the diagnosis of seborrheic dermatitis. (See <a href=\"topic.htm?path=seborrheic-dermatitis-in-adolescents-and-adults\" class=\"medical medical_review\">&quot;Seborrheic dermatitis in adolescents and adults&quot;</a> and <a href=\"topic.htm?path=cradle-cap-and-seborrheic-dermatitis-in-infants\" class=\"medical medical_review\">&quot;Cradle cap and seborrheic dermatitis in infants&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Psoriasis</strong> &ndash;In contrast with atopic dermatitis, in infants and young children, psoriasis often involves the diaper area, with well-demarcated erythematous patches with little scale (<a href=\"image.htm?imageKey=DERM%2F99441%7EDERM%2F95639\" class=\"graphic graphic_picture graphicRef99441 graphicRef95639 \">picture 14A-B</a>). (See <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of psoriasis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Scabies</strong> &ndash; Scabies may present as a diffuse eruption mimicking atopic dermatitis (<a href=\"image.htm?imageKey=PC%2F52588\" class=\"graphic graphic_picture graphicRef52588 \">picture 15</a>). The involvement of the skin folds (and, in infants, of the diaper area) and the presence of vesicopustules on the palms and sole suggest the diagnosis of scabies. The demonstration of mites or eggs by skin scraping, dermoscopy, or adhesive tape test can confirm the diagnosis. (See <a href=\"topic.htm?path=scabies-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Scabies: Epidemiology, clinical features, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Less common conditions that may be confused with atopic dermatitis include:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Drug reactions (<a href=\"image.htm?imageKey=DERM%2F54205\" class=\"graphic graphic_picture graphicRef54205 \">picture 16</a>) (see <a href=\"topic.htm?path=exanthematous-maculopapular-drug-eruption\" class=\"medical medical_review\">&quot;Exanthematous (maculopapular) drug eruption&quot;</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Primary immunodeficiencies, including Wiskott-Aldrich syndrome (<a href=\"image.htm?imageKey=DERM%2F95686\" class=\"graphic graphic_picture graphicRef95686 \">picture 17</a>) and hyperimmunoglobulin E syndrome (<a href=\"image.htm?imageKey=ALLRG%2F61049\" class=\"graphic graphic_picture graphicRef61049 \">picture 18</a>) (see <a href=\"topic.htm?path=wiskott-aldrich-syndrome\" class=\"medical medical_review\">&quot;Wiskott-Aldrich syndrome&quot;</a> and <a href=\"topic.htm?path=autosomal-dominant-hyperimmunoglobulin-e-syndrome\" class=\"medical medical_review\">&quot;Autosomal dominant hyperimmunoglobulin E syndrome&quot;</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Nutritional deficiencies, acrodermatitis enteropathica (<a href=\"image.htm?imageKey=PEDS%2F71329\" class=\"graphic graphic_picture graphicRef71329 \">picture 19</a>) (see <a href=\"topic.htm?path=zinc-deficiency-and-supplementation-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Zinc deficiency and supplementation in children and adolescents&quot;</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Netherton syndrome (<a href=\"image.htm?imageKey=DERM%2F87482%7EDERM%2F87481\" class=\"graphic graphic_picture graphicRef87482 graphicRef87481 \">picture 20A-B</a>) (see <a href=\"topic.htm?path=overview-and-classification-of-the-inherited-ichthyoses#H5808386\" class=\"medical medical_review\">&quot;Overview and classification of the inherited ichthyoses&quot;, section on 'Netherton syndrome'</a>)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Cutaneous T cell lymphoma (see <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-mycosis-fungoides\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H3695164431\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-atopic-dermatitis\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Atopic dermatitis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=eczema-atopic-dermatitis-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Eczema (atopic dermatitis) (The Basics)&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topics (see <a href=\"topic.htm?path=atopic-dermatitis-eczema-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Atopic dermatitis (eczema) (Beyond the Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H15\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Atopic dermatitis is a chronic pruritic inflammatory skin disease that occurs most frequently in children, but also affects adults. A family history of atopy (eczema, asthma, or allergic rhinitis) and the loss-of-function mutations in the filaggrin (<em>FLG</em>) gene, involved in the skin barrier function, are major risk factors for atopic dermatitis. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above and <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above and <a href=\"#H55133484\" class=\"local\">'Risk factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The cardinal features of atopic dermatitis are dry skin and severe pruritus that is associated with cutaneous hyperreactivity to various environmental stimuli, including exposure to food and inhalant allergens, irritants, and infection. Erythema, papulation, oozing and crusting, excoriation, and lichenification vary with the patient's age and stage of lesions. (See <a href=\"#H11\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of atopic dermatitis is clinical, based upon history, morphology, and distribution of skin lesions and associated clinical signs. Diagnostic criteria for the clinical diagnosis include:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Evidence of pruritic skin (mandatory), plus three or more of the following major criteria</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>History of dermatitis involving the skin creases</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Visible dermatitis involving flexural surfaces</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Personal or family history of asthma or hay fever </p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Presence of generally dry skin within the past year</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Symptoms beginning in a child before the age of 2 years or, in children &lt;4 years, dermatitis affecting the cheeks or dorsal aspect of extremities</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Skin biopsy and laboratory testing, including immunoglobulin E (IgE) levels, are usually not necessary in patients felt clinically to have atopic dermatitis. (See <a href=\"#H12\" class=\"local\">'Diagnosis'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/1\" class=\"nounderline abstract_t\">Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol 2010; 105:99.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/2\" class=\"nounderline abstract_t\">Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol 2014; 70:338.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/3\" class=\"nounderline abstract_t\">Williams H, Flohr C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol 2006; 118:209.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/4\" class=\"nounderline abstract_t\">Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103:125.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/5\" class=\"nounderline abstract_t\">Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol 2011; 131:67.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/6\" class=\"nounderline abstract_t\">Vinding GR, Zarchi K, Ibler KS, et al. Is adult atopic eczema more common than we think? - A population-based study in Danish adults. Acta Derm Venereol 2014; 94:480.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/7\" class=\"nounderline abstract_t\">R&ouml;nmark EP, Ekerljung L, L&ouml;tvall J, et al. Eczema among adults: prevalence, risk factors and relation to airway diseases. Results from a large-scale population survey in Sweden. Br J Dermatol 2012; 166:1301.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/8\" class=\"nounderline abstract_t\">Mortz CG, Andersen KE, Dellgren C, et al. Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities. Allergy 2015; 70:836.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/9\" class=\"nounderline abstract_t\">Deckers IA, McLean S, Linssen S, et al. Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies. PLoS One 2012; 7:e39803.</a></li><li class=\"breakAll\">Kang K, Polster AM, Nedorost St, et al. Atopic dermatitis. In: Dermatology, Bolognia JL, Jorizzo JL, Rapini RP, et al (Eds), Mosby, New York 2003. p.199.</li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/11\" class=\"nounderline abstract_t\">Sandstr&ouml;m MH, Faergemann J. Prognosis and prognostic factors in adult patients with atopic dermatitis: a long-term follow-up questionnaire study. Br J Dermatol 2004; 150:103.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/12\" class=\"nounderline abstract_t\">Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365:1315.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/13\" class=\"nounderline abstract_t\">Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Cochrane Database Syst Rev 2012; :CD000133.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/14\" class=\"nounderline abstract_t\">Flohr C, Yeo L. Atopic dermatitis and the hygiene hypothesis revisited. Curr Probl Dermatol 2011; 41:1.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/15\" class=\"nounderline abstract_t\">McNally NJ, Williams HC, Phillips DR, et al. Atopic eczema and domestic water hardness. Lancet 1998; 352:527.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/16\" class=\"nounderline abstract_t\">Miyake Y, Yokoyama T, Yura A, et al. Ecological association of water hardness with prevalence of childhood atopic dermatitis in a Japanese urban area. Environ Res 2004; 94:33.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/17\" class=\"nounderline abstract_t\">Arnedo-Pena A, Bellido-Blasco J, Puig-Barbera J, et al. [Domestic water hardness and prevalence of atopic eczema in Castellon (Spain) school children]. Salud Publica Mex 2007; 49:295.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/18\" class=\"nounderline abstract_t\">Chaumont A, Voisin C, Sardella A, Bernard A. Interactions between domestic water hardness, infant swimming and atopy in the development of childhood eczema. Environ Res 2012; 116:52.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/19\" class=\"nounderline abstract_t\">Perkin MR, Craven J, Logan K, et al. Association between domestic water hardness, chlorine, and atopic dermatitis risk in early life: A&nbsp;population-based cross-sectional study. J Allergy Clin Immunol 2016; 138:509.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/20\" class=\"nounderline abstract_t\">Kuo IH, Yoshida T, De Benedetto A, Beck LA. The cutaneous innate immune response in patients with atopic dermatitis. J Allergy Clin Immunol 2013; 131:266.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/21\" class=\"nounderline abstract_t\">Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242:233.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/22\" class=\"nounderline abstract_t\">Elias PM, Wakefield JS. Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol 2014; 134:781.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/23\" class=\"nounderline abstract_t\">Feingold KR, Elias PM. Role of lipids in the formation and maintenance of the cutaneous permeability barrier. Biochim Biophys Acta 2014; 1841:280.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/24\" class=\"nounderline abstract_t\">Leung DY. New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol Int 2013; 62:151.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/25\" class=\"nounderline abstract_t\">Brandner JM, Zorn-Kruppa M, Yoshida T, et al. Epidermal tight junctions in health and disease. Tissue Barriers 2015; 3:e974451.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/26\" class=\"nounderline abstract_t\">Seidenari S, Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol 1995; 75:429.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/27\" class=\"nounderline abstract_t\">Kelleher M, Dunn-Galvin A, Hourihane JO, et al. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year. J Allergy Clin Immunol 2015; 135:930.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/28\" class=\"nounderline abstract_t\">Flohr C, England K, Radulovic S, et al. Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age. Br J Dermatol 2010; 163:1333.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/29\" class=\"nounderline abstract_t\">Gupta J, Grube E, Ericksen MB, et al. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J Allergy Clin Immunol 2008; 121:725.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/30\" class=\"nounderline abstract_t\">Mischke D, Korge BP, Marenholz I, et al. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex (&quot;epidermal differentiation complex&quot;) on human chromosome 1q21. J Invest Dermatol 1996; 106:989.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/31\" class=\"nounderline abstract_t\">Sandilands A, Sutherland C, Irvine AD, McLean WH. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 2009; 122:1285.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/32\" class=\"nounderline abstract_t\">Broccardo CJ, Mahaffey S, Schwarz J, et al. Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization. J Allergy Clin Immunol 2011; 127:186.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/33\" class=\"nounderline abstract_t\">De Benedetto A, Rafaels NM, McGirt LY, et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 2011; 127:773.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/34\" class=\"nounderline abstract_t\">Weidinger S, Illig T, Baurecht H, et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006; 118:214.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/35\" class=\"nounderline abstract_t\">Larsen FS, Holm NV, Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1986; 15:487.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/36\" class=\"nounderline abstract_t\">Schultz Larsen F. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993; 28:719.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/37\" class=\"nounderline abstract_t\">Rodr&iacute;guez E, Baurecht H, Herberich E, et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009; 123:1361.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/38\" class=\"nounderline abstract_t\">Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38:441.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/39\" class=\"nounderline abstract_t\">Esparza-Gordillo J, Weidinger S, F&ouml;lster-Holst R, et al. A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet 2009; 41:596.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/40\" class=\"nounderline abstract_t\">Sun LD, Xiao FL, Li Y, et al. Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population. Nat Genet 2011; 43:690.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/41\" class=\"nounderline abstract_t\">Paternoster L, Standl M, Chen CM, et al. Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis. Nat Genet 2011; 44:187.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/42\" class=\"nounderline abstract_t\">Hirota T, Takahashi A, Kubo M, et al. Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population. Nat Genet 2012; 44:1222.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/43\" class=\"nounderline abstract_t\">Liao H, Waters AJ, Goudie DR, et al. Filaggrin mutations are genetic modifying factors exacerbating X-linked ichthyosis. J Invest Dermatol 2007; 127:2795.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/44\" class=\"nounderline abstract_t\">Gruber R, Wilson NJ, Smith FJ, et al. Increased pachyonychia congenita severity in patients with concurrent keratin and filaggrin mutations. Br J Dermatol 2009; 161:1391.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/45\" class=\"nounderline abstract_t\">van den Oord RA, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009; 339:b2433.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/46\" class=\"nounderline abstract_t\">Rupnik H, Rijavec M, Koro&scaron;ec P. Filaggrin loss-of-function mutations are not associated with atopic dermatitis that develops in late childhood or adulthood. Br J Dermatol 2015; 172:455.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/47\" class=\"nounderline abstract_t\">Heede NG, Thyssen JP, Thuesen BH, et al. Anatomical patterns of dermatitis in adult filaggrin mutation carriers. J Am Acad Dermatol 2015; 72:440.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/48\" class=\"nounderline abstract_t\">Chang J, Mitra N, Hoffstad O, Margolis DJ. Association of Filaggrin Loss of Function and Thymic Stromal Lymphopoietin Variation With Treatment Use in Pediatric Atopic Dermatitis. JAMA Dermatol 2017; 153:275.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/49\" class=\"nounderline abstract_t\">Hovnanian A. Netherton syndrome: skin inflammation and allergy by loss of protease inhibition. Cell Tissue Res 2013; 351:289.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/50\" class=\"nounderline abstract_t\">Cork MJ, Robinson DA, Vasilopoulos Y, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006; 118:3.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/51\" class=\"nounderline abstract_t\">Walley AJ, Chavanas S, Moffatt MF, et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet 2001; 29:175.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/52\" class=\"nounderline abstract_t\">Kato A, Fukai K, Oiso N, et al. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol 2003; 148:665.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/53\" class=\"nounderline abstract_t\">Lan CC, Tu HP, Wu CS, et al. Distinct SPINK5 and IL-31 polymorphisms are associated with atopic eczema and non-atopic hand dermatitis in Taiwanese nursing population. Exp Dermatol 2011; 20:975.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/54\" class=\"nounderline abstract_t\">Zhao LP, Di Z, Zhang L, et al. Association of SPINK5 gene polymorphisms with atopic dermatitis in Northeast China. J Eur Acad Dermatol Venereol 2012; 26:572.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/55\" class=\"nounderline abstract_t\">Guttman-Yassky E, Su&aacute;rez-Fari&ntilde;as M, Chiricozzi A, et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J Allergy Clin Immunol 2009; 124:1235.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/56\" class=\"nounderline abstract_t\">Barnes KC. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol 2010; 125:16.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/57\" class=\"nounderline abstract_t\">Portelli MA, Hodge E, Sayers I. Genetic risk factors for the development of allergic disease identified by genome-wide association. Clin Exp Allergy 2015; 45:21.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/58\" class=\"nounderline abstract_t\">Saunders SP, Goh CS, Brown SJ, et al. Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects. J Allergy Clin Immunol 2013; 132:1121.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/59\" class=\"nounderline abstract_t\">Kuo IH, Carpenter-Mendini A, Yoshida T, et al. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol 2013; 133:988.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/60\" class=\"nounderline abstract_t\">De Benedetto A, Agnihothri R, McGirt LY, et al. Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol 2009; 129:14.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/61\" class=\"nounderline abstract_t\">Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 2012; 22:850.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/62\" class=\"nounderline abstract_t\">Macias ES, Pereira FA, Rietkerk W, Safai B. Superantigens in dermatology. J Am Acad Dermatol 2011; 64:455.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/63\" class=\"nounderline abstract_t\">Fallon PG, Sasaki T, Sandilands A, et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 2009; 41:602.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/64\" class=\"nounderline abstract_t\">Leung DY, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol 2014; 134:769.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/65\" class=\"nounderline abstract_t\">Takai T. TSLP expression: cellular sources, triggers, and regulatory mechanisms. Allergol Int 2012; 61:3.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/66\" class=\"nounderline abstract_t\">Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006; 203:269.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/67\" class=\"nounderline abstract_t\">Sokol CL, Barton GM, Farr AG, Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 2008; 9:310.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/68\" class=\"nounderline abstract_t\">Ziegler SF, Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 2010; 11:289.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/69\" class=\"nounderline abstract_t\">Gao PS, Rafaels NM, Mu D, et al. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol 2010; 125:1403.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/70\" class=\"nounderline abstract_t\">Margolis DJ, Kim B, Apter AJ, et al. Thymic stromal lymphopoietin variation, filaggrin loss of function, and the persistence of atopic dermatitis. JAMA Dermatol 2014; 150:254.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/71\" class=\"nounderline abstract_t\">Rudikoff D, Lebwohl M. Atopic dermatitis. Lancet 1998; 351:1715.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/72\" class=\"nounderline abstract_t\">Pugliarello S, Cozzi A, Gisondi P, Girolomoni G. Phenotypes of atopic dermatitis. J Dtsch Dermatol Ges 2011; 9:12.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/73\" class=\"nounderline abstract_t\">Deleuran M, Vestergaard C. Clinical heterogeneity and differential diagnosis of atopic dermatitis. Br J Dermatol 2014; 170 Suppl 1:2.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/74\" class=\"nounderline abstract_t\">Juli&aacute;n-G&oacute;nzalez RE, Orozco-Covarrubias L, Dur&aacute;n-McKinster C, et al. Less common clinical manifestations of atopic dermatitis: prevalence by age. Pediatr Dermatol 2012; 29:580.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/75\" class=\"nounderline abstract_t\">Simpson EL, Thompson MM, Hanifin JM. Prevalence and morphology of hand eczema in patients with atopic dermatitis. Dermatitis 2006; 17:123.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/76\" class=\"nounderline abstract_t\">Brans R, H&uuml;bner A, Gediga G, John SM. Prevalence of foot eczema and associated occupational and non-occupational factors in patients with hand eczema. Contact Dermatitis 2015; 73:100.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/77\" class=\"nounderline abstract_t\">Wolf R, Orion E, T&uuml;z&uuml;n Y. Periorbital (eyelid) dermatides. Clin Dermatol 2014; 32:131.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/78\" class=\"nounderline abstract_t\">Kulthanan K, Samutrapong P, Jiamton S, Tuchinda P. Adult-onset atopic dermatitis: a cross-sectional study of natural history and clinical manifestation. Asian Pac J Allergy Immunol 2007; 25:207.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/79\" class=\"nounderline abstract_t\">Williams HC, Strachan DP. The natural history of childhood eczema: observations from the British 1958 birth cohort study. Br J Dermatol 1998; 139:834.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/80\" class=\"nounderline abstract_t\">Burr ML, Dunstan FD, Hand S, et al. The natural history of eczema from birth to adult life: a cohort study. Br J Dermatol 2013; 168:1339.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/81\" class=\"nounderline abstract_t\">Garmhausen D, Hagemann T, Bieber T, et al. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy 2013; 68:498.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/82\" class=\"nounderline abstract_t\">Kim JP, Chao LX, Simpson EL, Silverberg JI. Persistence of atopic dermatitis (AD): A systematic review and meta-analysis. J Am Acad Dermatol 2016; 75:681.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/83\" class=\"nounderline abstract_t\">Matiz C, Tom WL, Eichenfield LF, et al. Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: the San Diego experience. Pediatr Dermatol 2011; 28:6.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/84\" class=\"nounderline abstract_t\">Balma-Mena A, Lara-Corrales I, Zeller J, et al. Colonization with community-acquired methicillin-resistant Staphylococcus aureus in children with atopic dermatitis: a cross-sectional study. Int J Dermatol 2011; 50:682.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/85\" class=\"nounderline abstract_t\">Huang JT, Abrams M, Tlougan B, et al. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009; 123:e808.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/86\" class=\"nounderline abstract_t\">Leung DY. Why is eczema herpeticum unexpectedly rare? Antiviral Res 2013; 98:153.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/87\" class=\"nounderline abstract_t\">von Kobyletzki LB, Bornehag CG, Hasselgren M, et al. Eczema in early childhood is strongly associated with the development of asthma and rhinitis in a prospective cohort. BMC Dermatol 2012; 12:11.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/88\" class=\"nounderline abstract_t\">Bantz SK, Zhu Z, Zheng T. The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma. J Clin Cell Immunol 2014; 5.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/89\" class=\"nounderline abstract_t\">Wan J, Mitra N, Hoffstad OJ, et al. Variations in risk of asthma and seasonal allergies between early- and late-onset pediatric atopic dermatitis: A cohort study. J Am Acad Dermatol 2017; 77:634.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/90\" class=\"nounderline abstract_t\">Eigenmann PA, Calza AM. Diagnosis of IgE-mediated food allergy among Swiss children with atopic dermatitis. Pediatr Allergy Immunol 2000; 11:95.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/91\" class=\"nounderline abstract_t\">Garc&iacute;a C, El-Qutob D, Martorell A, et al. Sensitization in early age to food allergens in children with atopic dermatitis. Allergol Immunopathol (Madr) 2007; 35:15.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/92\" class=\"nounderline abstract_t\">Bartnikas LM, Gurish MF, Burton OT, et al. Epicutaneous sensitization results in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis. J Allergy Clin Immunol 2013; 131:451.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/93\" class=\"nounderline abstract_t\">Brough HA, Simpson A, Makinson K, et al. Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations. J Allergy Clin Immunol 2014; 134:867.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/94\" class=\"nounderline abstract_t\">Brough HA, Liu AH, Sicherer S, et al. Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy. J Allergy Clin Immunol 2015; 135:164.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/95\" class=\"nounderline abstract_t\">Eigenmann PA, Sicherer SH, Borkowski TA, et al. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 1998; 101:E8.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/96\" class=\"nounderline abstract_t\">Gray CL, Levin ME, Zar HJ, et al. Food allergy in South African children with atopic dermatitis. Pediatr Allergy Immunol 2014; 25:572.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/97\" class=\"nounderline abstract_t\">Eller E, Kjaer HF, H&oslash;st A, et al. Food allergy and food sensitization in early childhood: results from the DARC cohort. Allergy 2009; 64:1023.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/98\" class=\"nounderline abstract_t\">Kvenshagen B, Jacobsen M, Halvorsen R. Atopic dermatitis in premature and term children. Arch Dis Child 2009; 94:202.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/99\" class=\"nounderline abstract_t\">Spergel JM, Boguniewicz M, Schneider L, et al. Food Allergy in Infants With Atopic Dermatitis: Limitations of Food-Specific IgE Measurements. Pediatrics 2015; 136:e1530.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/100\" class=\"nounderline abstract_t\">Bremmer SF, Hanifin JM, Simpson EL. Clinical detection of ichthyosis vulgaris in an atopic dermatitis clinic: implications for allergic respiratory disease and prognosis. J Am Acad Dermatol 2008; 59:72.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/101\" class=\"nounderline abstract_t\">Tay YK, Kong KH, Khoo L, et al. The prevalence and descriptive epidemiology of atopic dermatitis in Singapore school children. Br J Dermatol 2002; 146:101.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/102\" class=\"nounderline abstract_t\">Chen JJ, Applebaum DS, Sun GS, Pflugfelder SC. Atopic keratoconjunctivitis: A review. J Am Acad Dermatol 2014; 70:569.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/103\" class=\"nounderline abstract_t\">Pattnaik L, Acharya L. A comprehensive review on vernal keratoconjunctivitis with emphasis on proteomics. Life Sci 2015; 128:47.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/104\" class=\"nounderline abstract_t\">Silverberg JI, Becker L, Kwasny M, et al. Central obesity and high blood pressure in pediatric patients with atopic dermatitis. JAMA Dermatol 2015; 151:144.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/105\" class=\"nounderline abstract_t\">Silverberg JI, Kleiman E, Lev-Tov H, et al. Association between obesity and atopic dermatitis in childhood: a case-control study. J Allergy Clin Immunol 2011; 127:1180.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/106\" class=\"nounderline abstract_t\">Silverberg JI, Silverberg NB, Lee-Wong M. Association between atopic dermatitis and obesity in adulthood. Br J Dermatol 2012; 166:498.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/107\" class=\"nounderline abstract_t\">Kusunoki T, Morimoto T, Nishikomori R, et al. Obesity and the prevalence of allergic diseases in schoolchildren. Pediatr Allergy Immunol 2008; 19:527.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/108\" class=\"nounderline abstract_t\">Luo X, Xiang J, Dong X, et al. Association between obesity and atopic disorders in Chinese adults: an individually matched case-control study. BMC Public Health 2013; 13:12.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/109\" class=\"nounderline abstract_t\">Drucker AM, Qureshi AA, Dummer TJB, et al. Atopic dermatitis and risk of hypertension, type 2 diabetes, myocardial infarction and stroke in a cross-sectional analysis from the Canadian Partnership for Tomorrow Project. Br J Dermatol 2017; 177:1043.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/110\" class=\"nounderline abstract_t\">Zhang A, Silverberg JI. Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis. J Am Acad Dermatol 2015; 72:606.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/111\" class=\"nounderline abstract_t\">Drury KE, Schaeffer M, Silverberg JI. Association Between Atopic Disease and Anemia in US Children. JAMA Pediatr 2016; 170:29.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/112\" class=\"nounderline abstract_t\">Yaghmaie P, Koudelka CW, Simpson EL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol 2013; 131:428.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/113\" class=\"nounderline abstract_t\">Slattery MJ, Essex MJ, Paletz EM, et al. Depression, anxiety, and dermatologic quality of life in adolescents with atopic dermatitis. J Allergy Clin Immunol 2011; 128:668.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/114\" class=\"nounderline abstract_t\">Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006; 60:984.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/115\" class=\"nounderline abstract_t\">Chen MH, Su TP, Chen YS, et al. Is atopy in early childhood a risk factor for ADHD and ASD? a longitudinal study. J Psychosom Res 2014; 77:316.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/116\" class=\"nounderline abstract_t\">Shyu CS, Lin HK, Lin CH, Fu LS. Prevalence of attention-deficit/hyperactivity disorder in patients with pediatric allergic disorders: a nationwide, population-based study. J Microbiol Immunol Infect 2012; 45:237.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/117\" class=\"nounderline abstract_t\">Schmitt J, Buske-Kirschbaum A, Roessner V. Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review. Allergy 2010; 65:1506.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/118\" class=\"nounderline abstract_t\">Strom MA, Fishbein AB, Paller AS, Silverberg JI. Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults. Br J Dermatol 2016; 175:920.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/119\" class=\"nounderline abstract_t\">Romanos M, Gerlach M, Warnke A, Schmitt J. Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health 2010; 64:269.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/120\" class=\"nounderline abstract_t\">Buske-Kirschbaum A, Schmitt J, Plessow F, et al. Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoneuroendocrinology 2013; 38:12.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/121\" class=\"nounderline abstract_t\">Cheng CM, Hsu JW, Huang KL, et al. Risk of developing major depressive disorder and anxiety disorders among adolescents and adults with atopic dermatitis: a nationwide longitudinal study. J Affect Disord 2015; 178:60.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/122\" class=\"nounderline abstract_t\">Arana A, Wentworth CE, Fern&aacute;ndez-Vidaurre C, et al. Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K. Br J Dermatol 2010; 163:1036.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/123\" class=\"nounderline abstract_t\">Vajdic CM, Falster MO, de Sanjose S, et al. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res 2009; 69:6482.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/124\" class=\"nounderline abstract_t\">Legendre L, Barnetche T, Mazereeuw-Hautier J, et al. Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis. J Am Acad Dermatol 2015; 72:992.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/125\" class=\"nounderline abstract_t\">Arellano FM, Wentworth CE, Arana A, et al. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol 2007; 127:808.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/126\" class=\"nounderline abstract_t\">Arellano FM, Arana A, Wentworth CE, et al. Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom. J Allergy Clin Immunol 2009; 123:1111.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/127\" class=\"nounderline abstract_t\">Margolis D, Bilker W, Hennessy S, et al. The risk of malignancy associated with psoriasis. Arch Dermatol 2001; 137:778.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/128\" class=\"nounderline abstract_t\">Hui RL, Lide W, Chan J, et al. Association between exposure to topical tacrolimus or pimecrolimus and cancers. Ann Pharmacother 2009; 43:1956.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/129\" class=\"nounderline abstract_t\">Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med 2005; 352:2314.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/130\" class=\"nounderline abstract_t\">Williams HC, Burney PG, Pembroke AC, Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994; 131:406.</a></li><li><a href=\"https://www.uptodate.com/contents/atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis/abstract/131\" class=\"nounderline abstract_t\">Brenninkmeijer EE, Schram ME, Leeflang MM, et al. Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol 2008; 158:754.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 1729 Version 31.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H15\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H55133484\" id=\"outline-link-H55133484\">RISK FACTORS</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">PATHOGENESIS</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">Epidermal barrier</a><ul><li><a href=\"#H58962847\" id=\"outline-link-H58962847\">- Filaggrin</a></li><li><a href=\"#H55102489\" id=\"outline-link-H55102489\">- Other proteins in the stratum corneum</a></li><li><a href=\"#H55102333\" id=\"outline-link-H55102333\">- Tight junction-related proteins</a></li></ul></li><li><a href=\"#H14448090\" id=\"outline-link-H14448090\">Genetics</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">- FLG mutations</a></li><li><a href=\"#H1317229342\" id=\"outline-link-H1317229342\">- SPINK5</a></li><li><a href=\"#H14448287\" id=\"outline-link-H14448287\">- Other genes</a></li></ul></li><li><a href=\"#H79161793\" id=\"outline-link-H79161793\">Immune dysregulation</a><ul><li><a href=\"#H143637185\" id=\"outline-link-H143637185\">- Innate immune response</a></li><li><a href=\"#H323533778\" id=\"outline-link-H323533778\">- Adaptive immune response</a></li><li><a href=\"#H143636767\" id=\"outline-link-H143636767\">- Thymic stromal lymphopoietin</a></li></ul></li></ul></li><li><a href=\"#H98844203\" id=\"outline-link-H98844203\">PATHOLOGY</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H1974708121\" id=\"outline-link-H1974708121\">Common features</a></li><li><a href=\"#H43807123\" id=\"outline-link-H43807123\">Associated features</a></li><li><a href=\"#H3942787364\" id=\"outline-link-H3942787364\">Clinical variants</a></li><li><a href=\"#H4291280\" id=\"outline-link-H4291280\">Clinical course and complications</a></li></ul></li><li><a href=\"#H80247225\" id=\"outline-link-H80247225\">COMORBIDITIES</a><ul><li><a href=\"#H86702391\" id=\"outline-link-H86702391\">Allergic rhinitis, asthma, and food allergy</a></li><li><a href=\"#H55134481\" id=\"outline-link-H55134481\">Ichthyosis vulgaris</a></li><li><a href=\"#H4291555\" id=\"outline-link-H4291555\">Eye diseases</a></li><li><a href=\"#H86702411\" id=\"outline-link-H86702411\">Obesity and metabolic syndrome</a></li><li><a href=\"#H1208373967\" id=\"outline-link-H1208373967\">Anemia</a></li><li><a href=\"#H28253721\" id=\"outline-link-H28253721\">Psychiatric disorders</a><ul><li><a href=\"#H371998464\" id=\"outline-link-H371998464\">- Attention deficit hyperactivity disorder</a></li><li><a href=\"#H28253734\" id=\"outline-link-H28253734\">- Depression and anxiety disorder</a></li></ul></li></ul></li><li><a href=\"#H406735829\" id=\"outline-link-H406735829\">RISK OF LYMPHOMA</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">DIAGNOSIS</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H3695164431\" id=\"outline-link-H3695164431\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H14\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/1729|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ALLRG/77457\" class=\"graphic graphic_picture\">- Infantile atopic dermatitis widespread</a></li><li><a href=\"image.htm?imageKey=ALLRG/56461\" class=\"graphic graphic_picture\">- Atopic dermatitis infantile II</a></li><li><a href=\"image.htm?imageKey=DERM/77386\" class=\"graphic graphic_picture\">- Atopic dermatitis infant 2</a></li><li><a href=\"image.htm?imageKey=DERM/68746\" class=\"graphic graphic_picture\">- Atopic dermatitis infant</a></li><li><a href=\"image.htm?imageKey=DERM/68215\" class=\"graphic graphic_picture\">- Atopic dermatitis popliteal</a></li><li><a href=\"image.htm?imageKey=PC/65407\" class=\"graphic graphic_picture\">- Severe atopic dermatitis</a></li><li><a href=\"image.htm?imageKey=PC/52163\" class=\"graphic graphic_picture\">- Flexural atopic dermatitis</a></li><li><a href=\"image.htm?imageKey=DERM/55424\" class=\"graphic graphic_picture\">- Atopic dermatitis papular</a></li><li><a href=\"image.htm?imageKey=DERM/102395\" class=\"graphic graphic_picture\">- Atopic dermatitis neck</a></li><li><a href=\"image.htm?imageKey=DERM/64525\" class=\"graphic graphic_picture\">- Adult atopic dermatitis 1</a></li><li><a href=\"image.htm?imageKey=DERM/55375\" class=\"graphic graphic_picture\">- Adult chronic atopic dermatitis</a></li><li><a href=\"image.htm?imageKey=DERM/60786\" class=\"graphic graphic_picture\">- Keratosis pilaris light skin</a></li><li><a href=\"image.htm?imageKey=DERM/68488\" class=\"graphic graphic_picture\">- Keratosis pilaris dark skin</a></li><li><a href=\"image.htm?imageKey=DERM/60866\" class=\"graphic graphic_picture\">- Pityriasis alba 1</a></li><li><a href=\"image.htm?imageKey=DERM/62145\" class=\"graphic graphic_picture\">- Dennie-Morgan fold</a></li><li><a href=\"image.htm?imageKey=DERM/91322\" class=\"graphic graphic_picture\">- Atopic cheilitis</a></li><li><a href=\"image.htm?imageKey=PC/64142\" class=\"graphic graphic_picture\">- Eczema herpeticum face</a></li><li><a href=\"image.htm?imageKey=PC/74838\" class=\"graphic graphic_picture\">- Eczema herpeticum hand</a></li><li><a href=\"image.htm?imageKey=PC/51337\" class=\"graphic graphic_picture\">- Eczema herpeticum arm</a></li><li><a href=\"image.htm?imageKey=DERM/90481\" class=\"graphic graphic_picture\">- Ichthyosis vulgaris palmar hyperlinearity</a></li><li><a href=\"image.htm?imageKey=DERM/51066\" class=\"graphic graphic_picture\">- Contact dermatitis allergic 1</a></li><li><a href=\"image.htm?imageKey=DERM/73813\" class=\"graphic graphic_picture\">- Seborrheic dermatitis diaper area</a></li><li><a href=\"image.htm?imageKey=DERM/56410\" class=\"graphic graphic_picture\">- Seborrheic dermatitis face</a></li><li><a href=\"image.htm?imageKey=DERM/59104\" class=\"graphic graphic_picture\">- Seborrheic dermatitis face 2</a></li><li><a href=\"image.htm?imageKey=DERM/99441\" class=\"graphic graphic_picture\">- Diaper psoriasis</a></li><li><a href=\"image.htm?imageKey=DERM/95639\" class=\"graphic graphic_picture\">- Psoriasis infant</a></li><li><a href=\"image.htm?imageKey=PC/52588\" class=\"graphic graphic_picture\">- Scabies infant trunk</a></li><li><a href=\"image.htm?imageKey=DERM/54205\" class=\"graphic graphic_picture\">- Morbilliform drug eruption</a></li><li><a href=\"image.htm?imageKey=DERM/95686\" class=\"graphic graphic_picture\">- Wiskott-Aldrich dermatitis</a></li><li><a href=\"image.htm?imageKey=ALLRG/61049\" class=\"graphic graphic_picture\">- Severe eczema hyper IgE</a></li><li><a href=\"image.htm?imageKey=PEDS/71329\" class=\"graphic graphic_picture\">- Acrodermatitis enteropathica</a></li><li><a href=\"image.htm?imageKey=DERM/87482\" class=\"graphic graphic_picture\">- Ichthyosis linearis circumflexa in Netherton syndrome</a></li><li><a href=\"image.htm?imageKey=DERM/87481\" class=\"graphic graphic_picture\">- Netherton syndrome</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=an-overview-of-the-innate-immune-system\" class=\"medical medical_review\">An overview of the innate immune system</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=atopic-keratoconjunctivitis\" class=\"medical medical_review\">Atopic keratoconjunctivitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=attention-deficit-hyperactivity-disorder-in-adults-epidemiology-pathogenesis-clinical-features-course-assessment-and-diagnosis\" class=\"medical medical_review\">Attention deficit hyperactivity disorder in adults: Epidemiology, pathogenesis, clinical features, course, assessment, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=attention-deficit-hyperactivity-disorder-in-children-and-adolescents-clinical-features-and-diagnosis\" class=\"medical medical_review\">Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=attention-deficit-hyperactivity-disorder-in-children-and-adolescents-epidemiology-and-pathogenesis\" class=\"medical medical_review\">Attention deficit hyperactivity disorder in children and adolescents: Epidemiology and pathogenesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=autosomal-dominant-hyperimmunoglobulin-e-syndrome\" class=\"medical medical_review\">Autosomal dominant hyperimmunoglobulin E syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cheilitis\" class=\"medical medical_review\">Cheilitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=chronic-hand-eczema\" class=\"medical medical_review\">Chronic hand eczema</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-allergic-contact-dermatitis\" class=\"medical medical_review\">Clinical features and diagnosis of allergic contact dermatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-mycosis-fungoides\" class=\"medical medical_review\">Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cradle-cap-and-seborrheic-dermatitis-in-infants\" class=\"medical medical_review\">Cradle cap and seborrheic dermatitis in infants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis\" class=\"medical medical_review\">Epidemiology, clinical manifestations, and diagnosis of psoriasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=exanthematous-maculopapular-drug-eruption\" class=\"medical medical_review\">Exanthematous (maculopapular) drug eruption</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=food-allergy-in-children-prevalence-natural-history-and-monitoring-for-resolution\" class=\"medical medical_review\">Food allergy in children: Prevalence, natural history, and monitoring for resolution</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=keratosis-pilaris\" class=\"medical medical_review\">Keratosis pilaris</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-severe-atopic-dermatitis-eczema-in-children\" class=\"medical medical_review\">Management of severe atopic dermatitis (eczema) in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nummular-eczema\" class=\"medical medical_review\">Nummular eczema</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-and-classification-of-the-inherited-ichthyoses\" class=\"medical medical_review\">Overview and classification of the inherited ichthyoses</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=atopic-dermatitis-eczema-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Atopic dermatitis (eczema) (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=eczema-atopic-dermatitis-the-basics\" class=\"medical medical_basics\">Patient education: Eczema (atopic dermatitis) (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prurigo-nodularis\" class=\"medical medical_review\">Prurigo nodularis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=role-of-allergy-in-atopic-dermatitis-eczema\" class=\"medical medical_review\">Role of allergy in atopic dermatitis (eczema)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=scabies-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">Scabies: Epidemiology, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=seborrheic-dermatitis-in-adolescents-and-adults\" class=\"medical medical_review\">Seborrheic dermatitis in adolescents and adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-atopic-dermatitis\" class=\"medical medical_society_guidelines\">Society guideline links: Atopic dermatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=the-adaptive-cellular-immune-response\" class=\"medical medical_review\">The adaptive cellular immune response</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-atopic-dermatitis-eczema\" class=\"medical medical_review\">Treatment of atopic dermatitis (eczema)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vernal-keratoconjunctivitis\" class=\"medical medical_review\">Vernal keratoconjunctivitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=wiskott-aldrich-syndrome\" class=\"medical medical_review\">Wiskott-Aldrich syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=zinc-deficiency-and-supplementation-in-children-and-adolescents\" class=\"medical medical_review\">Zinc deficiency and supplementation in children and adolescents</a></li></ul></div></div>","javascript":null}